Indication
Mycobacterium avium complex lung disease
2 clinical trials
3 products
1 drug
Clinical trial
A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole in Patients With Treatment-refractory Mycobacterium Avium Complex Lung DiseaseStatus: Active (not recruiting), Estimated PCD: 2025-09-01
Product
PlaceboProduct
EpetraboroleClinical trial
ICoN-1: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Efficacy and Safety of Clofazamine Inhalation Suspension When Added to Guideline-Based Therapy in Participants With Nontuberculous Mycobacterial InfectionStatus: Not yet recruiting, Estimated PCD: 2026-08-01
Product
ClofazimineDrug
Varlilumab